IRIS
CARAMORI, Gaetano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.331
EU - Europa 9.181
AS - Asia 7.852
SA - Sud America 3.684
Continente sconosciuto - Info sul continente non disponibili 534
AF - Africa 222
OC - Oceania 13
Totale 39.817
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.028
RU - Federazione Russa 5.433
BR - Brasile 3.106
SG - Singapore 2.955
CN - Cina 2.433
IE - Irlanda 1.417
HK - Hong Kong 880
VN - Vietnam 690
IT - Italia 677
SE - Svezia 589
FR - Francia 378
AR - Argentina 211
DE - Germania 177
BD - Bangladesh 141
IN - India 138
PL - Polonia 110
CA - Canada 103
EC - Ecuador 101
GB - Regno Unito 93
CO - Colombia 87
ID - Indonesia 83
MX - Messico 82
TR - Turchia 81
FI - Finlandia 62
ZA - Sudafrica 62
IQ - Iraq 60
VE - Venezuela 53
UA - Ucraina 48
PY - Paraguay 42
PK - Pakistan 41
UZ - Uzbekistan 39
MA - Marocco 38
JP - Giappone 37
CL - Cile 33
NL - Olanda 31
BE - Belgio 27
AT - Austria 26
PE - Perù 23
TN - Tunisia 23
KE - Kenya 21
MY - Malesia 21
AE - Emirati Arabi Uniti 20
AZ - Azerbaigian 20
JM - Giamaica 20
JO - Giordania 20
ES - Italia 19
KZ - Kazakistan 19
NP - Nepal 17
UY - Uruguay 17
CR - Costa Rica 16
EG - Egitto 16
TH - Thailandia 15
IL - Israele 14
PA - Panama 14
AL - Albania 13
SA - Arabia Saudita 13
DO - Repubblica Dominicana 12
OM - Oman 12
PH - Filippine 12
AU - Australia 11
BG - Bulgaria 11
BO - Bolivia 11
CZ - Repubblica Ceca 11
HN - Honduras 11
TT - Trinidad e Tobago 11
SN - Senegal 10
CH - Svizzera 9
DZ - Algeria 9
GE - Georgia 9
KR - Corea 9
LK - Sri Lanka 9
LT - Lituania 9
NI - Nicaragua 9
TW - Taiwan 9
CI - Costa d'Avorio 8
ET - Etiopia 8
GR - Grecia 8
GT - Guatemala 8
KG - Kirghizistan 8
BH - Bahrain 7
AM - Armenia 6
AO - Angola 6
IR - Iran 6
PS - Palestinian Territory 5
RS - Serbia 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
CG - Congo 4
LB - Libano 4
BN - Brunei Darussalam 3
BZ - Belize 3
EE - Estonia 3
KW - Kuwait 3
LV - Lettonia 3
MK - Macedonia 3
RO - Romania 3
BB - Barbados 2
Totale 39.246
Salva come PNG Salva come JPEG
Città #
Moscow 2.027
Ashburn 1.636
Dublin 1.417
Singapore 1.179
Hong Kong 874
Dallas 847
Beijing 691
Chandler 537
Dearborn 510
The Dalles 440
San Jose 428
Nyköping 397
Council Bluffs 370
Princeton 326
Lauterbourg 277
Jacksonville 270
Ho Chi Minh City 264
São Paulo 252
Atlanta 249
Des Moines 233
Los Angeles 225
San Mateo 224
Cambridge 219
Messina 199
Medford 167
Hanoi 143
Redondo Beach 128
Jinan 116
Tianjin 113
Buffalo 111
Shenyang 110
Warsaw 106
Rio de Janeiro 94
Santa Clara 92
New York 91
Belo Horizonte 76
Guangzhou 68
Nanjing 64
Orem 64
Curitiba 61
Munich 61
Wilmington 61
Ningbo 58
Memphis 57
Zhengzhou 57
Ann Arbor 48
Hebei 47
Brasília 45
Bremen 45
Rome 42
Naples 41
Shanghai 40
Haikou 39
Nanchang 39
Porto Alegre 39
Campinas 38
Lanzhou 38
Tashkent 38
Hangzhou 37
Pune 37
Haiphong 36
Milan 36
Salvador 35
Turku 34
Quito 33
San Francisco 33
Denver 30
Montreal 30
Tokyo 30
Chicago 29
Guarulhos 28
Taizhou 28
Bogotá 27
Brooklyn 27
Baghdad 26
Guayaquil 26
Ribeirão Preto 26
Chennai 25
Brussels 24
Da Nang 24
London 24
Santo André 24
Jakarta 23
Asunción 22
Changsha 22
Fortaleza 22
Phoenix 22
Seattle 22
Shenzhen 22
Frankfurt am Main 21
Dhaka 20
Fuzhou 20
Goiânia 20
Istanbul 20
Johannesburg 20
Thái Bình 20
Caxias do Sul 19
Maceió 19
Nairobi 19
Baku 18
Totale 17.608
Salva come PNG Salva come JPEG
Nome #
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. Basi fisiologiche. I parte. 346
Polmonite interstiziale fibrosante da amiodarone 263
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 259
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. 233
Asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study. 225
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease 218
Anti-inflammatory mechanisms of glucocorticoids targeting granulocytes. 216
Attuali progressi nel trattamento dell’asma bronchiale nell’adulto. 215
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 213
An unusual cause of chest pain 212
Expression of Heat Shock Proteins 70 and 90 in COPD Peripheral Lung 209
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive.Basi fisiologiche. II parte. 208
Overlap and common correlates between depression and COPD: a narrative review 207
Increased deposition of activated complement in peripheral lung vessels of smokers 206
Malattie virali dell’apparato respiratorio 205
New insights into the molecular mechanisms of corticosteroids actions. 203
Quality of life in asthma and COPD: is it measurable in primary care? 202
Cytokine inhibition in the treatment of COPD. 200
Oxidative/nitrosative stress selectively altered A2B adenosine receptors in chronic obstructive pulmonary disease. 199
Asma. 198
Near-fatal asthma phenotype in the ENFUMOSA Cohort. 197
AN UNUSUAL CASE OF CHRONIC AIRFLOW OBSTRUCTION IN A HEAVY SMOKER 197
Anti-inflammatory treatments for asthma: past, present, future. 196
Heat shock proteins 70 and 90 expression in peripheral lung of COPD patients 195
I glucocorticoidi inalatori sono poco efficaci nel trattamento delle BPCO in fase stabile. 195
Effect of acute and chronic inflammatory stimuli on expression of protease-activated receptors 1 and 2 in alveolar macrophages. 194
Congenital diaphragmatic hernia in an adult simulating a pleural liposarcoma. 194
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: patologia. 194
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 194
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease 193
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy. 193
Nuove linee guida internazionali per la terapia farmacologica dell’asma. 192
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 192
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 191
Hereditary hyperhomocysteinemia associated with nephrotic syndrome complicated by artery thrombosis and chronic thromboembolic pulmonary hypertension: A case report 191
A case of fibrosing interstitial pneumonia 191
Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression and inhibits glucocorticoid actions in alveolar macrophages. 190
Impact of theophylline/corticosteroid combination therapy on sputum hydrogen sulfide levels in patients with COPD 189
Parassiti e polmoni. 189
An unusual cause of dyspnoea in a patient with chronic ischemic heart disease 189
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. 188
COPD immunopathology 187
Cellule staminali e patologia polmonare dell’adulto 187
Low-dose theophylline does not exert its anti-inflammatory effects in mild asthma through upregulation of interleukin-10 in alveolar macrophages. 187
Molecular links between COPD and lung cancer: new targets for drug discovery? 187
Role of nitric oxide in allergic inflammation and bronchial hyperresponsiveness. 186
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 184
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients 184
MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients 183
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. 183
Increased expression of ccl4/mip-1β in cd8+ cells and cd4+ cells in sarcoidosis. 183
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension. 183
Decreased percentage of CD4+Foxp3+TGF-β+ and increased percentage of CD4+IL-17+ cells in bronchoalveolar lavage of asthmatics 183
Teofillina: effetti polmonari ed extrapolmonari nei pazienti con asma e BPCO; nuove prospettive. 182
Targeting Th2 cells in asthmatic patients. 182
New drugs targeting Th2 lymphocytes in asthma. 182
Mechanisms of respiratory virus-induced asthma exacerbations 182
Role of Stem Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Pulmonary Emphysema 182
Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease 181
Is there a difference between chronic airway inflammation in chronic severe asthma and chronic obstructive pulmonary disease? 181
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 181
Differential expression of IL-10 receptor by epithelial cells and alveolar macrophages. 181
Clinical definition of COPD exacerbations and classification of their severity. 180
Fattori genetici nell’asma e nella BPCO. 180
Definition, clinical features, investigations and differential diagnosis in asthma 180
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. 179
COPD in nonsmokers: the biomass hypothesis - to be or not to be? 179
Marcatori infiammatori nella diagnosi e nel monitoraggio dell’ asma. 179
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD 178
Expression of transforming growth factors beta (1, 2, 3) and connective tissue growth factor in the peripheral lung from GOLD stage 1-2 COPD patients and smokers with normal lung function 178
Smoking history effect on peripheral lung inflammation and gene transcription in chronic obstructive pulmonary disease 178
Autoimmunity and COPD: Clinical Implications 177
Pathogenic link between chronic obstructive pulmonary disease and squamous cell lung cancer 176
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 176
Global lung function standardisation: finally making our dream a reality? 176
Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. 176
Tubercolosi extrapolmonare a carico dell’apparato genitale femminile con reazione a catena polimerasica negativa per micobatterio tubercolare. 175
Patologia vascolare polmonare 175
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 175
Rhinovirus induces MUC5AC in a human infection model, and in vitro via NF-{kappa}B and EGFR pathways 174
Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD. 174
Broncodilatatori nella terapia delle broncopneumopatie croniche ostruttive. 173
Oxidants and asthma 173
Gli antagonisti dei leucotrieni: nuove speranze nella terapia dell'asma? 172
Evaluation by self-monitoring and noninvasive measures. 172
Decreased T-lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease. 170
Tubercolosi: vaccinazione e chemioprofilassi come prevenzione 170
Broncodilatatori nell’asma e nelle broncopneumopatie croniche ostruttive. 169
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines 169
A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis 169
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 168
Subcutaneous emphysema of the chest wall: a case with unusual presentation. 168
Th17-related cytokine expression is increased in the bronchial mucosa of stable COPD patients 168
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations. 168
[Risk of diabetes mellitus during regular long-term inhaled glucocorticoid treatment in COPD patients: narrative review of the literature.] 167
Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease 166
Implementazione delle linee guida sull’asma bronchiale in Italia: l’opinione del medico di medicina generale. 162
Evaluation of Innate Immune Mediators Related to Respiratory Viruses in the Lung of Stable COPD Patients 160
Bacterial infections in the lungs of patients with systemic autoimmune diseases 159
Role of the mucins in pathogenesis of COPD: implications for therapy 158
Totale 18.878
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.363
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.660 0 65 5 273 27 13 181 87 19 72 335 583
2022/20232.889 365 187 104 152 133 182 35 96 1.547 8 52 28
2023/2024865 52 81 54 84 70 169 24 30 5 27 11 258
2024/20256.085 74 28 80 313 210 55 91 1.419 1.596 357 706 1.156
2025/202615.174 544 1.069 1.450 1.817 967 3.102 1.764 1.527 1.551 589 348 446
2026/202710.256 978 9.278 0 0 0 0 0 0 0 0 0 0
Totale 39.817